{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T04:04:42Z","timestamp":1793505882542,"version":"4.5.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.juro.2010.06.149","type":"journal-article","created":{"date-parts":[[2010,9,18]],"date-time":"2010-09-18T08:27:19Z","timestamp":1284798439000},"page":"1920-1924","source":"Crossref","is-referenced-by-count":8,"title":["Safety and Efficacy of Intravesical Bacillus Calmette-Gu\u00e9rin Plus Interferon \u03b1-2b Therapy for Nonmuscle Invasive Bladder Cancer in Patients With Prosthetic Devices"],"prefix":"10.1097","volume":"184","author":[{"given":"Henry M.","family":"Rosevear","sequence":"first","affiliation":[{"name":"Department of Urology, University of Iowa, Iowa City, Iowa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Lightfoot","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Iowa, Iowa City, Iowa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth G.","family":"Nepple","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Iowa, Iowa City, Iowa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"O'Donnell","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Iowa, Iowa City, Iowa"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2010.06.149_bib1","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1016\/j.juro.2007.09.003","article-title":"Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update","volume":"178","author":"Hall","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2010.06.149_bib2","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/S0022-5347(01)63160-4","article-title":"Superficial bladder cancer: the role of interferon-alpha","volume":"159","author":"Belldegrun","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2010.06.149_bib3","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/00002371-200307000-00006","article-title":"Phase 1 study of the intravesical administration of recombinant human interleukin-12 in patients with recurrent superficial transitional cell carcinoma of the bladder","volume":"26","author":"Weiss","year":"2003","journal-title":"J Immunother"},{"key":"10.1016\/j.juro.2010.06.149_bib4","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.urolonc.2005.11.026","article-title":"Final results from a national multicenter phase II trial of combination bacillus Calmette-Guerin plus interferon alpha-2B for reducing recurrence of superficial bladder cancer","volume":"24","author":"Joudi","year":"2006","journal-title":"Urol Oncol"},{"key":"10.1016\/j.juro.2010.06.149_bib5","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0022-5347(17)58737-6","article-title":"Intracavitary bacillus Calmette-Guerin in the treatment of superficial bladder tumors","volume":"116","author":"Morales","year":"1976","journal-title":"J Urol"},{"issue":"suppl.","key":"10.1016\/j.juro.2010.06.149_bib6","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1086\/314064","article-title":"Efficacy and safety of bacille Calmette-Guerin immunotherapy in superficial bladder cancer","volume":"31","author":"Lamm","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.juro.2010.06.149_bib7","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.juro.2006.03.066","article-title":"Safety and efficacy of intravesical bacillus Calmette-Guerin instillations in steroid treated and immunocompromised patients","volume":"176","author":"Yossepowitch","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2010.06.149_bib8","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1097\/01.TP.0000090748.32764.0F","article-title":"Intravesical bacillus Calmette-Guerin for the treatment of superficial bladder cancer in renal transplant patients","volume":"76","author":"Palou","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.juro.2010.06.149_bib9","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1093\/clind\/16.6.825","article-title":"Mycobacterium bovis infection of an implantable defibrillator following intravesical therapy with bacille Calmette-Guerin","volume":"16","author":"Stone","year":"1993","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.juro.2010.06.149_bib10","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.arth.2006.07.010","article-title":"Infected total hip arthroplasty after intravesical bacillus Calmette-Guerin therapy","volume":"22","author":"Segal","year":"2007","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.juro.2010.06.149_bib11","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1302\/0301-620X.90B2.20038","article-title":"A total hip replacement infected with mycobacterium bovis after intravesicular treatment with Bacille-Calmette-Guerin for bladder cancer","volume":"90","author":"Reigstad","year":"2008","journal-title":"J Bone Joint Surg Br"},{"key":"10.1016\/j.juro.2010.06.149_bib12","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jbspin.2004.12.003","article-title":"Osteoarticular side effects of BCG therapy","volume":"73","author":"Clavel","year":"2006","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.juro.2010.06.149_bib13","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1086\/514714","article-title":"Mycobacterium bovis osteomyelitis involving a hip arthroplasty after intravesicular bacille Calmette-Guerin for bladder cancer","volume":"27","author":"Guerra","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.juro.2010.06.149_bib14","doi-asserted-by":"crossref","first-page":"711","DOI":"10.2214\/ajr.167.3.8751686","article-title":"Infected aortic aneurysm and vertebral osteomyelitis after intravesical bacillus Calmette-Guerin therapy","volume":"167","author":"Rozenblit","year":"1996","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.juro.2010.06.149_bib15","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1097\/00007611-199512000-00005","article-title":"Vascular and other serious infections with Mycobacterium bovis after bacillus of Calmette-Guerin therapy for bladder cancer","volume":"88","author":"Hellinger","year":"1995","journal-title":"South Med J"},{"key":"10.1016\/j.juro.2010.06.149_bib16","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0741-5214(95)70092-7","article-title":"Infection of a ruptured aortic aneurysm and an aortic graft with bacille Calmette-Guerin after intravesical administration for bladder cancer","volume":"22","author":"Wolf","year":"1995","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.juro.2010.06.149_bib17","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1161\/CIRCULATIONAHA.106.183095","volume":"116","author":"Wilson","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.juro.2010.06.149_bib18","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.juro.2008.01.068","article-title":"Best practice policy statement on urologic surgery antimicrobial prophylaxis","volume":"179","author":"Wolf","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2010.06.149_bib19","first-page":"447","article-title":"Comment on the 2009 American Academy of Orthopaedic Surgeons' information statement on antibiotic prophylaxis for bacteremia in patients with joint replacements","volume":"75","author":"Napenas","year":"2009","journal-title":"J Can Dent Assoc"},{"key":"10.1016\/j.juro.2010.06.149_bib20","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.urology.2007.07.017","article-title":"The safety and efficacy of different doses of bacillus Calmette Guerin in superficial bladder transitional cell carcinoma","volume":"70","author":"Agrawal","year":"2007","journal-title":"Urology"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534710040711?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534710040711?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2010.06.149","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T01:46:35Z","timestamp":1651196795000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2010.06.149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["10.1016\/j.juro.2010.06.149"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2010.06.149","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}